NORMACOL Granules (2021)
Βιβλιογραφική αναφορά
Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Περιεχόμενα
1. Name of the medicinal product
Normacol 62% w/w Granules.
2. Qualitative and quantitative composition
Each gram of NORMACOL Granules contains 0.62g of Sterculia BP (62% w/w). Each sachet contains 4.34g of Sterculia BP. <u>Excipient(s) with know effect:</u> Contains 1.7g of sucrose and 28.7mg of sodium ...
3. Pharmaceutical form
Granules. White irregular shaped granules.
4.1. Therapeutic indications
The treatment of constipation (including pregnancy and lactation). Management of colostomies and ileostomies. The High Residue Diet management of diverticular disease of the colon and other conditions ...
4.2. Posology and method of administration
Adults 1 or 2 sachets or 1-2 heaped 5ml spoonfuls, once or twice daily after meals. Older People As adult dose. Paediatric population <u>Children (6-12 years):</u> one half the above amount or as directed ...
4.3. Contraindications
Intestinal obstruction, faecal impaction, and colonic atony. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency. Known hypersensitivity ...
4.4. Special warnings and precautions for use
Adequate fluid intake should be maintained. Caution should be exercised in cases of ulcerative colitis. Patients should be advised: of possible fluid and electrolyte depletion in association with diarrhoea. ...
4.5. Interaction with other medicinal products and other forms of interaction
None known.
4.6. Pregnancy and lactation
NORMACOL may be used during pregnancy or lactation.
4.7. Effects on ability to drive and use machines
NORMACOL has no influence on the ability to drive or use machines.
4.8. Undesirable effects
System Order Class Adverse Drug Reaction <b>Immune system disorders</b> Allergic reactions <b>Gastrointestinal disorders</b> Oesophageal obstruction, intestinal<br />obstruction or impaction, abdominal ...
4.9. Overdose
Intestinal obstruction is possible in overdosage particularly in combination with inadequate fluid intake. Management is as for intestinal obstruction from other causes. Oesophageal obstruction is possible ...
5.1. Pharmacodynamic properties
NORMACOL is a laxative which contains sterculia. Sterculia is a bulking agent which stimulates the motility of the colon by increasing faecal volume, and reduces intraluminal recto-sigmoid pressure. Sterculia ...
5.2. Pharmacokinetic properties
Sterculia is not absorbed or digested in the gastrointestinal tract and its laxative action is normally effective within 12 hours of oral administration.
5.3. Preclinical safety data
There is no evidence that Sterculia has a significant systemic toxicity potential.
6.1. List of excipients
Sucrose Talc Sodium hydrogen carbonate Hard paraffin Titanium dioxide (E171) Vanillin
6.2. Incompatibilities
None known.
6.3. Shelf life
<u>Sachet and carton:</u> 2 years.
6.4. Special precautions for storage
<u>Sachet:</u> Do not store above 25°C. Store in the original package in a dry place. <u>Carton:</u> Do not store above 25°C. Store in the original package in a dry place. Keep the carton tightly closed. ...
6.5. Nature and contents of container
<u>Sachet:</u> Laminate consisting of 4 layers of low density polyethylene; aluminium; low density polyethylene and paper. Each sachet contains 7g of white granules supplied in boxes of 2,7 or 60 sachets. ...
6.6. Special precautions for disposal and other handling
No special requirements.
7. Marketing authorization holder
Norgine B.V., Antonio Vivaldistraat 150, 1083 HP Amsterdam, Netherlands
8. Marketing authorization number(s)
PA1336/007/001
9. Date of first authorization / renewal of the authorization
Date of first authorisation: 25 September 1984 Date of last renewal: 25 September 2009
10. Date of revision of the text
January 2021
Πηγαίο έγγραφο
Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση: